LINC00513: A Drug Target / Disease Biomarker (G100506860)

Target Name: LINC00513

NCBI ID: G100506860

LINC00513

Other Name(s): Long intergenic non-protein coding RNA 513 | long intergenic non-protein coding RNA 513

LINC00513: A Drug Target / Disease Biomarker

LINC00513 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and biology have made it an attractive target for researchers to study and develop new treatments.

LINC00513 is a long non-coding RNA molecule that is found in almost all cell types. It is characterized by its ability to interact with protein-coding genes and enhance their expression levels. This interaction between LINC00513 and proteins has led to its involvement in various cellular processes, including cell growth, apoptosis, and inflammation.

One of the key features of LINC00513 is its ability to form a complex with a protein called NF-kappa-B, which is a transcription factor that plays a role in regulating gene expression and cell signaling. This complex formation has led to the hypothesis that LINC00513 may be a drug target for diseases that are characterized by disruptions in NF-kappa-B signaling.

In cancer, LINC00513 has been shown to be highly expressed in various types of cancer, including breast, lung, and ovarian cancer. It has also been shown to be involved in the regulation of cell cycle progression, which is a key aspect of cancer development.

In addition to its role in cancer, LINC00513 has also been shown to be involved in a variety of other cellular processes, including cell signaling, inflammation, and neurodegeneration. This diverse range of functions has made it an attractive target for researchers to study and develop new treatments for a variety of diseases.

One of the challenges in studying LINC00513 as a drug target is its complex biology and interactions with other proteins. However, researchers have made significant progress in understanding its role in various cellular processes and its potential as a drug target.

In conclusion, LINC00513 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases. Its unique structure and biology have made it an attractive target for researchers to study and develop new treatments. Further research is needed to fully understand its role in various cellular processes and its potential as a drug target.

Protein Name: Long Intergenic Non-protein Coding RNA 513

The "LINC00513 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00513 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets